CN1242217A - 葛根素药物组合物及其制备 - Google Patents
葛根素药物组合物及其制备 Download PDFInfo
- Publication number
- CN1242217A CN1242217A CN 99100213 CN99100213A CN1242217A CN 1242217 A CN1242217 A CN 1242217A CN 99100213 CN99100213 CN 99100213 CN 99100213 A CN99100213 A CN 99100213A CN 1242217 A CN1242217 A CN 1242217A
- Authority
- CN
- China
- Prior art keywords
- pharmaceutical composition
- puerarin
- composition according
- freeze
- sodium
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 5
- 239000003814 drug Substances 0.000 title abstract description 12
- 241000219780 Pueraria Species 0.000 title 1
- 239000000843 powder Substances 0.000 claims abstract description 30
- 208000029078 coronary artery disease Diseases 0.000 claims abstract description 4
- RXUWDKBZZLIASQ-UHFFFAOYSA-N Puerarin Natural products OCC1OC(Oc2c(O)cc(O)c3C(=O)C(=COc23)c4ccc(O)cc4)C(O)C(O)C1O RXUWDKBZZLIASQ-UHFFFAOYSA-N 0.000 claims description 45
- HKEAFJYKMMKDOR-VPRICQMDSA-N puerarin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1C1=C(O)C=CC(C2=O)=C1OC=C2C1=CC=C(O)C=C1 HKEAFJYKMMKDOR-VPRICQMDSA-N 0.000 claims description 45
- 238000004108 freeze drying Methods 0.000 claims description 26
- 239000008194 pharmaceutical composition Substances 0.000 claims description 17
- 238000001035 drying Methods 0.000 claims description 9
- 238000002360 preparation method Methods 0.000 claims description 9
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 claims description 8
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 claims description 7
- 239000000243 solution Substances 0.000 claims description 7
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 7
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 claims description 6
- 238000000034 method Methods 0.000 claims description 6
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 claims description 6
- 239000008215 water for injection Substances 0.000 claims description 5
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 claims description 4
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 claims description 4
- 229930195725 Mannitol Natural products 0.000 claims description 4
- 150000001413 amino acids Chemical class 0.000 claims description 4
- 239000003963 antioxidant agent Substances 0.000 claims description 4
- 230000003078 antioxidant effect Effects 0.000 claims description 4
- 150000007529 inorganic bases Chemical group 0.000 claims description 4
- GUBGYTABKSRVRQ-QKKXKWKRSA-N lactose group Chemical group OC1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@H](O)[C@@H](O)[C@@H](O)[C@H](O2)CO)[C@H](O1)CO GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 claims description 4
- 239000000594 mannitol Substances 0.000 claims description 4
- 235000010355 mannitol Nutrition 0.000 claims description 4
- 239000000546 pharmaceutical excipient Substances 0.000 claims description 4
- 229910000029 sodium carbonate Inorganic materials 0.000 claims description 4
- AKHNMLFCWUSKQB-UHFFFAOYSA-L sodium thiosulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=S AKHNMLFCWUSKQB-UHFFFAOYSA-L 0.000 claims description 4
- 235000019345 sodium thiosulphate Nutrition 0.000 claims description 4
- 239000004475 Arginine Substances 0.000 claims description 3
- 206010008088 Cerebral artery embolism Diseases 0.000 claims description 3
- ZGTMUACCHSMWAC-UHFFFAOYSA-L EDTA disodium salt (anhydrous) Chemical compound [Na+].[Na+].OC(=O)CN(CC([O-])=O)CCN(CC(O)=O)CC([O-])=O ZGTMUACCHSMWAC-UHFFFAOYSA-L 0.000 claims description 3
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 claims description 3
- 239000004472 Lysine Substances 0.000 claims description 3
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 claims description 3
- 201000010849 intracranial embolism Diseases 0.000 claims description 3
- 239000008101 lactose Substances 0.000 claims description 3
- 229910000027 potassium carbonate Inorganic materials 0.000 claims description 3
- 235000011181 potassium carbonates Nutrition 0.000 claims description 3
- HRZFUMHJMZEROT-UHFFFAOYSA-L sodium disulfite Chemical compound [Na+].[Na+].[O-]S(=O)S([O-])(=O)=O HRZFUMHJMZEROT-UHFFFAOYSA-L 0.000 claims description 3
- 235000010262 sodium metabisulphite Nutrition 0.000 claims description 3
- ODKSFYDXXFIFQN-BYPYZUCNSA-P L-argininium(2+) Chemical compound NC(=[NH2+])NCCC[C@H]([NH3+])C(O)=O ODKSFYDXXFIFQN-BYPYZUCNSA-P 0.000 claims description 2
- HNDVDQJCIGZPNO-YFKPBYRVSA-N L-histidine Chemical compound OC(=O)[C@@H](N)CC1=CN=CN1 HNDVDQJCIGZPNO-YFKPBYRVSA-N 0.000 claims description 2
- KDXKERNSBIXSRK-YFKPBYRVSA-N L-lysine Chemical compound NCCCC[C@H](N)C(O)=O KDXKERNSBIXSRK-YFKPBYRVSA-N 0.000 claims description 2
- UIIMBOGNXHQVGW-DEQYMQKBSA-M Sodium bicarbonate-14C Chemical compound [Na+].O[14C]([O-])=O UIIMBOGNXHQVGW-DEQYMQKBSA-M 0.000 claims description 2
- 239000000890 drug combination Substances 0.000 claims description 2
- HNDVDQJCIGZPNO-UHFFFAOYSA-N histidine Natural products OC(=O)C(N)CC1=CN=CN1 HNDVDQJCIGZPNO-UHFFFAOYSA-N 0.000 claims description 2
- 229910052757 nitrogen Inorganic materials 0.000 claims description 2
- 239000011736 potassium bicarbonate Substances 0.000 claims description 2
- 229910000028 potassium bicarbonate Inorganic materials 0.000 claims description 2
- 235000015497 potassium bicarbonate Nutrition 0.000 claims description 2
- TYJJADVDDVDEDZ-UHFFFAOYSA-M potassium hydrogencarbonate Chemical compound [K+].OC([O-])=O TYJJADVDDVDEDZ-UHFFFAOYSA-M 0.000 claims description 2
- 235000011118 potassium hydroxide Nutrition 0.000 claims description 2
- 235000017550 sodium carbonate Nutrition 0.000 claims description 2
- 235000011121 sodium hydroxide Nutrition 0.000 claims description 2
- 239000002552 dosage form Substances 0.000 claims 1
- 238000002347 injection Methods 0.000 abstract description 14
- 239000007924 injection Substances 0.000 abstract description 14
- 239000006184 cosolvent Substances 0.000 abstract description 4
- 231100000331 toxic Toxicity 0.000 abstract description 4
- 230000002588 toxic effect Effects 0.000 abstract description 4
- 238000003860 storage Methods 0.000 abstract description 3
- 239000007788 liquid Substances 0.000 abstract description 2
- ULWHHBHJGPPBCO-UHFFFAOYSA-N propane-1,1-diol Chemical compound CCC(O)O ULWHHBHJGPPBCO-UHFFFAOYSA-N 0.000 abstract description 2
- 208000007536 Thrombosis Diseases 0.000 abstract 1
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 9
- 238000004140 cleaning Methods 0.000 description 8
- 238000000108 ultra-filtration Methods 0.000 description 8
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 6
- 238000003756 stirring Methods 0.000 description 5
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 4
- 229940079593 drug Drugs 0.000 description 4
- 230000000694 effects Effects 0.000 description 3
- 238000002474 experimental method Methods 0.000 description 3
- 231100000419 toxicity Toxicity 0.000 description 3
- 230000001988 toxicity Effects 0.000 description 3
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- 239000007864 aqueous solution Substances 0.000 description 2
- 238000001914 filtration Methods 0.000 description 2
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 2
- 235000017557 sodium bicarbonate Nutrition 0.000 description 2
- GEHJYWRUCIMESM-UHFFFAOYSA-L sodium sulfite Chemical compound [Na+].[Na+].[O-]S([O-])=O GEHJYWRUCIMESM-UHFFFAOYSA-L 0.000 description 2
- JGSARLDLIJGVTE-UHFFFAOYSA-N 3,3-dimethyl-7-oxo-6-[(2-phenylacetyl)amino]-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid Chemical compound O=C1N2C(C(O)=O)C(C)(C)SC2C1NC(=O)CC1=CC=CC=C1 JGSARLDLIJGVTE-UHFFFAOYSA-N 0.000 description 1
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 230000009931 harmful effect Effects 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 1
- 239000003978 infusion fluid Substances 0.000 description 1
- 238000001990 intravenous administration Methods 0.000 description 1
- 238000010253 intravenous injection Methods 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 239000012982 microporous membrane Substances 0.000 description 1
- 239000000825 pharmaceutical preparation Substances 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 235000010265 sodium sulphite Nutrition 0.000 description 1
Landscapes
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Description
静脉注射 | 腹腔注射 | |||
LD50(mg/kg) | 95%可信限(mg/kg) | LD50(mg/kg) | 95%可信限(mg/kg) | |
葛根素注射液 | 634.3 | 583.8-689.2 | 1412.2 | 1377.8-1448.1 |
葛根素冻干粉针剂 | 653.8 | 594.6-697.2 | 1472.6 | 1397.8-1501.3 |
Claims (7)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN99100213A CN1074673C (zh) | 1998-07-17 | 1999-01-21 | 葛根素冻干粉针剂及其制备方法 |
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN98110350 | 1998-07-17 | ||
CN98110350.2 | 1998-07-17 | ||
CN99100213A CN1074673C (zh) | 1998-07-17 | 1999-01-21 | 葛根素冻干粉针剂及其制备方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN1242217A true CN1242217A (zh) | 2000-01-26 |
CN1074673C CN1074673C (zh) | 2001-11-14 |
Family
ID=25744666
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN99100213A Expired - Lifetime CN1074673C (zh) | 1998-07-17 | 1999-01-21 | 葛根素冻干粉针剂及其制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN1074673C (zh) |
Cited By (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN100427109C (zh) * | 2002-09-02 | 2008-10-22 | 北京大学安康药物研究院 | 一种复方葛根素制剂 |
CN102488649A (zh) * | 2011-11-27 | 2012-06-13 | 辽宁海神联盛制药有限公司 | 葛根素氯化纳注射液及其制备方法 |
CN102743349A (zh) * | 2012-06-25 | 2012-10-24 | 瑞阳制药有限公司 | 小体积葛根素冻干粉针、其制备方法及其生产装置 |
CN103520109A (zh) * | 2013-09-13 | 2014-01-22 | 浙江工业大学 | 一种葛根素固体分散剂的制备方法 |
CN104042625A (zh) * | 2014-05-28 | 2014-09-17 | 西北农林科技大学 | 碳酸氢钠在葛根素注射剂中的应用 |
CN104188956A (zh) * | 2014-09-28 | 2014-12-10 | 苏州普罗达生物科技有限公司 | 一种葛根素组合物及其制备方法 |
CN105476964A (zh) * | 2014-06-20 | 2016-04-13 | 浙江震元制药有限公司 | 含有氨丁三醇的注射用葛根素及其制备方法 |
CN106806349A (zh) * | 2015-11-30 | 2017-06-09 | 湖南恒生制药股份有限公司 | 葛根素冻干粉针剂及其制备方法 |
CN107093351A (zh) * | 2017-05-24 | 2017-08-25 | 聊城职业技术学院 | 一种仿真注射用青霉素钠制剂及其应用 |
CN113143861A (zh) * | 2021-06-15 | 2021-07-23 | 华北制药股份有限公司 | 一种注射用葛根素组合物及其制备方法 |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3744208A1 (de) * | 1987-12-24 | 1989-07-06 | Rieter Ag Maschf | Verfahren und vorrichtung fuer die uebertragung von informationen bei einer eine vielzahl von produktionsstellen aufweisenden herstellungsmaschine |
CN1054068C (zh) * | 1996-01-18 | 2000-07-05 | 陕西镇坪制药厂 | 制取葛根素的方法 |
CN1158712A (zh) * | 1996-12-31 | 1997-09-10 | 连云港王子矿泉水有限公司 | 葛根汤饮料 |
-
1999
- 1999-01-21 CN CN99100213A patent/CN1074673C/zh not_active Expired - Lifetime
Cited By (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN100427109C (zh) * | 2002-09-02 | 2008-10-22 | 北京大学安康药物研究院 | 一种复方葛根素制剂 |
CN102488649A (zh) * | 2011-11-27 | 2012-06-13 | 辽宁海神联盛制药有限公司 | 葛根素氯化纳注射液及其制备方法 |
CN102743349A (zh) * | 2012-06-25 | 2012-10-24 | 瑞阳制药有限公司 | 小体积葛根素冻干粉针、其制备方法及其生产装置 |
CN102743349B (zh) * | 2012-06-25 | 2015-07-01 | 瑞阳制药有限公司 | 小体积葛根素冻干粉针、其制备方法及其生产装置 |
CN103520109A (zh) * | 2013-09-13 | 2014-01-22 | 浙江工业大学 | 一种葛根素固体分散剂的制备方法 |
CN104042625A (zh) * | 2014-05-28 | 2014-09-17 | 西北农林科技大学 | 碳酸氢钠在葛根素注射剂中的应用 |
CN105476964A (zh) * | 2014-06-20 | 2016-04-13 | 浙江震元制药有限公司 | 含有氨丁三醇的注射用葛根素及其制备方法 |
CN104188956A (zh) * | 2014-09-28 | 2014-12-10 | 苏州普罗达生物科技有限公司 | 一种葛根素组合物及其制备方法 |
CN104188956B (zh) * | 2014-09-28 | 2016-04-27 | 威海紫光金奥力生物技术有限公司 | 一种葛根素组合物及其制备方法 |
CN106806349A (zh) * | 2015-11-30 | 2017-06-09 | 湖南恒生制药股份有限公司 | 葛根素冻干粉针剂及其制备方法 |
CN107093351A (zh) * | 2017-05-24 | 2017-08-25 | 聊城职业技术学院 | 一种仿真注射用青霉素钠制剂及其应用 |
CN113143861A (zh) * | 2021-06-15 | 2021-07-23 | 华北制药股份有限公司 | 一种注射用葛根素组合物及其制备方法 |
Also Published As
Publication number | Publication date |
---|---|
CN1074673C (zh) | 2001-11-14 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN1258379C (zh) | 肉毒杆菌毒素药物组合物 | |
FI101596B (fi) | Menetelmä valmistaa stabiili injisoitava florfenikolin farmaseuttinen seos | |
CA1099639A (en) | High calorie solutions of low molecular weight glucose polymer mixtures useful for intravenous administration | |
CN100531734C (zh) | 阿曲库铵冷冻干燥组合物 | |
CN1242217A (zh) | 葛根素药物组合物及其制备 | |
DK165620B (da) | Frysetoerret farmaceutisk praeparat indeholdende anthracyclinglycosider og et cosolubiliserende middel og fremgangsmaade til fremstilling heraf, anvendelse af praeparatet til fremstilling af et tumormiddel samt fremgangsmaade til fremstilling af en rekonstitueret injicerbar oploesning af praeparatet | |
EP0143478B1 (en) | Stable, aqueous, acidic solution of cis-platinum, suitable for injection | |
DE69925820T2 (de) | Zubereitungen zur stabilisierung von peg-interferon alpha konjugaten | |
JPH05500062A (ja) | 有用な組成物 | |
RU2110263C1 (ru) | Стерильный апирогенный раствор для инъекций противоопухолевого действия, содержащий физиологически приемлемую соль гликозида антрациклина | |
DE69837997T2 (de) | Lyophilisierbare pharmazeutische plazebozusammensetzung , insbesondere auf basis von proteinen oder polypeptiden, zur nachahmung eines arzneimittels | |
KR20090095668A (ko) | 포르시토사이드 주사제와 그 제조 방법 | |
DE60009926T2 (de) | Stabilisierung von gefriergetrocknetem kuchen | |
CN101020715A (zh) | 鹿茸神经生长因子(deer ngf)提取及其制备方法 | |
CN103989630B (zh) | 盐酸莫西沙星氯化钠注射液及其制备方法 | |
CN1449754A (zh) | 依达拉奉药物组合物及制备 | |
CN104224906A (zh) | 一种中药牛至油注射乳剂及其制备方法 | |
CN100560055C (zh) | 眼用凝胶及其制备方法 | |
DE60022759T2 (de) | Erythropoietin formulierungen des mehrfachdosis-typs | |
FI91710C (fi) | Menetelmä injektoitavan käyttövalmiin, säilytystä kestävän, steriilin antrasykliiniglykosidiliuoksen valmistamiseksi | |
US4289783A (en) | Etomidate-containing compositions | |
CN1194698C (zh) | 葛根素注射剂及其制备工艺 | |
CN1318087C (zh) | 去白蛋白神经生长因子制剂 | |
CN1733070A (zh) | 治疗心脑血管疾病的中药制剂及其制备方法 | |
CN101569589B (zh) | 注射用克林霉素磷酸酯及其制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C53 | Correction of patent for invention or patent application | ||
CB03 | Change of inventor or designer information |
Inventor after: Liu Dianbo Inventor after: Sun Shengmao Inventor after: Su Kajia Inventor before: Liu Dianbo Inventor before: Sun Shengmao Inventor before: Su Kajia Inventor before: Yang Die |
|
COR | Change of bibliographic data |
Free format text: CORRECT: INVENTOR; FROM: LIU DIANBO; SUN SHENGMAO; SU KAJIA; YANG YI TO: LIU DIANBO; SUN SHENGMAO; SU KAJIA |
|
C06 | Publication | ||
PB01 | Publication | ||
C53 | Correction of patent for invention or patent application | ||
CB02 | Change of applicant information |
Address after: 264003, No. 12, Po Yuen Road, Laishan District, Shandong, Yantai Applicant after: Luye Pharmaceutical Co., Ltd., Shandong Applicant before: Green Leaf Pharmaceutical Co. Ltd., Yantai |
|
COR | Change of bibliographic data |
Free format text: CORRECT: APPLICANT; FROM: YANTAI GREEN LEAF PHARMACEUTICAL CO. LTD. TO: SHANDONG GREEN LEAF PHARMACEUTICAL CO., LTD. |
|
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
ASS | Succession or assignment of patent right |
Owner name: SHANGDONG RUIYANG PHARMACEUTICAL CO., LTD. Free format text: FORMER OWNER: SHANDONG GREEN LEAF PHARMACEUTICAL CO., LTD. Effective date: 20020826 |
|
C41 | Transfer of patent application or patent right or utility model | ||
TR01 | Transfer of patent right |
Effective date of registration: 20020826 Address after: 256100 No. 6 Erlang Road, Yiyuan County, Zibo, Shandong Patentee after: Shandong Ruiyang Pharmaceutical Co., Ltd. Address before: 264003, No. 9, Po Yuen Road, Laishan District, Shandong, Yantai Patentee before: Luye Pharmaceutical Co., Ltd., Shandong |
|
C56 | Change in the name or address of the patentee |
Owner name: RUIYANG PHARMACY CO., LTD. Free format text: FORMER NAME OR ADDRESS: SHANGDONG RUIYANG PHARMACEUTICAL CO., LTD. |
|
CP01 | Change in the name or title of a patent holder |
Address after: No. 6 Erlangshan Road, Yiyuan County, Zibo City, Shandong Province: 256100 Patentee after: Reyoung Pharmaceutical Co., Ltd. Address before: No. 6 Erlangshan Road, Yiyuan County, Zibo City, Shandong Province: 256100 Patentee before: Shandong Ruiyang Pharmaceutical Co., Ltd. |
|
CX01 | Expiry of patent term |
Granted publication date: 20011114 |
|
CX01 | Expiry of patent term |